Fig. 3From: Comprehensive analysis to identify pseudogenes/lncRNAs-hsa-miR-200b-3p-COL5A2 network as a prognostic biomarker in gastric cancerCorrelations between COL5A2 expression and clinical data, including A overall survival (OS), B disease-specific survival (DSS), C T stage, D N stage, E M stage, and F pathologic stageBack to article page